Vaxart (VXRT) 10-Q2023 Q1 Quarterly report

Filed: 4 May 23, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accredited, agreed, alleviate, asterisk, attached, bid, Bill, BMGF, breast, breastfeeding, calendar, capacity, carefully, CEO, CiC, clarify, closed, closing, Code, compliance, consecutive, copy, cure, dataset, deficiency, delisted, delisting, description, discourage, doubt, effort, enable, entirety, epithelial, exempt, expanded, fail, Fall, falling, Figure, flat, foregoing, Foundation, grace, grow, gut, herewith, implement, implemented, impose, inaccurate, incorrect, indeterminable, industry, infant, interference, intestine, investor, lack, lactating, leave, lesser, Melinda, milk, monthly, mother, nascent, notice, notification, Panel, Passive, penny, placement, postpone, postponed, potent, practice, preceding, prove, proven, publicly, recipient, regain, registered, registration, reliance, rendered, resolve, respond, restore, restructuring, size, space, split, stabilize, step, stockpiling, strategic, susceptible, text, turn, undue, unknown, urged, workforce, written, youngest

Removed: abnormally, accurately, Additionally, adequacy, aerosol, affecting, Africa, allocation, area, begin, Beta, bioRxiv, Burlingame, campaign, certified, chain, Chancery, competing, decline, delay, Delta, demurrer, distancing, Duke, economy, elicit, embedded, emerge, estate, Europe, existing, expended, forecast, found, group, headcount, inception, India, indirectly, insignificant, international, Intraepithelial, leasehold, led, licensee, local, located, Lodi, logistical, mask, multiplied, notably, percentage, performed, planning, predicted, prefer, ratably, real, recovery, regional, relationship, remain, rental, repeat, resumed, retaining, reversed, rolling, scheduled, social, spend, tableted, tenant, terminate, terminated, timepoint, treat, uncollectible, unit, unpredictability, variable, wearing, Wisconsin

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated VXRT transcripts

VXRT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350), Andrei Floroiu, President and Chief Executive Officer of Vaxart, Inc. (the “Company”), and Phillip Lee, Chief Financial Officer of the Company, each hereby certifies that, to his knowledge:

(1)

The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

(2)

The information contained in the Periodic Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Periodic Report and results of operations of the Company for the period covered by the Periodic Report.

Date: May 4, 2023	By:	/s/ ANDREI FLOROIU
		Andrei Floroiu
		President and Chief Executive Officer
		(Principal Executive Officer)

Date: May 4, 2023	By:	/s/ PHILLIP LEE
		Phillip Lee
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906 of 18 U.S.C. § 1350 has been provided to Vaxart, Inc. and will be retained by Vaxart, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.